{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T04:34:24Z","timestamp":1778733264107,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.ejca.2015.07.009","type":"journal-article","created":{"date-parts":[[2015,8,5]],"date-time":"2015-08-05T22:44:38Z","timestamp":1438814678000},"page":"2386-2395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)\/T-cell lymphoma, nasal type"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3482-3331","authenticated-orcid":false,"given":"Jean-Marie","family":"Michot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renaud","family":"Mazeron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Danu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Lazarovici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ghez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Antosikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Willekens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali N.","family":"Chamseddine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronique","family":"Minard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peggy","family":"Dartigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Bosq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice","family":"Carde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge","family":"Koscielny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"De Botton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Ferme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore","family":"Girinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Ribrag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2015.07.009_b0005","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1023\/A:1008265532487","article-title":"Epidemiology of the non-Hodgkin\u2019s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin\u2019s Lymphoma Classification Project","volume":"9","author":"Anderson","year":"1998","journal-title":"Ann Oncol Off J Eur Soc Med Oncol ESMO"},{"key":"10.1016\/j.ejca.2015.07.009_b0010","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1182\/blood-2013-01-453233","article-title":"How I treat NK\/T-cell lymphomas","volume":"121","author":"Tse","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2015.07.009_b0015","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.ijrobp.2010.10.040","article-title":"Radiotherapy alone with curative intent in patients with stage I extranodal nasal-type NK\/T-cell lymphoma","volume":"82","author":"Li","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2015.07.009_b0020","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1200\/JCO.2005.03.2573","article-title":"Radiotherapy as primary treatment for stage IE and IIE nasal natural killer\/T-cell lymphoma","volume":"24","author":"Li","year":"2006","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejca.2015.07.009_b0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1200\/JCO.2000.18.1.54","article-title":"Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment","volume":"18","author":"Kim","year":"2000","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejca.2015.07.009_b0030","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s12185-012-1174-y","article-title":"Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE\/IIE extranodal natural killer\/T cell lymphoma, nasal type: 13-year follow-up in 135 patients","volume":"96","author":"Wang","year":"2012","journal-title":"Int J Hematol"},{"key":"10.1016\/j.ejca.2015.07.009_b0035","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1080\/10428190600565651","article-title":"Treatment outcome of front-line systemic chemotherapy for localized extranodal NK\/T cell lymphoma in nasal and upper aerodigestive tract","volume":"47","author":"Kim","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ejca.2015.07.009_b0040","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","article-title":"Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project","volume":"113","author":"Au","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2015.07.009_b0045","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1182\/blood-2010-09-307454","article-title":"Efficacy of l-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK\/T-cell lymphoma, a phase 2 study","volume":"117","author":"Jaccard","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2015.07.009_b0050","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1756-8722-6-44","article-title":"A prospective phase II study of l-asparaginase \u2013 CHOP plus radiation in newly diagnosed extranodal NK\/T-cell lymphoma, nasal type","volume":"6","author":"Lin","year":"2013","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"10.1016\/j.ejca.2015.07.009_b0055","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1200\/JCO.2009.23.8295","article-title":"Phase I\/II study of concurrent chemoradiotherapy for localized nasal natural killer\/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211","volume":"27","author":"Yamaguchi","year":"2009","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejca.2015.07.009_b0060","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2012-05-431460","article-title":"SMILE for natural killer\/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group","volume":"120","author":"Kwong","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2015.07.009_b0065","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00277-014-2244-4","article-title":"Early radiotherapy has an essential role for improving survival in patients with stage I-II nasal-type of NK\/T cell lymphoma treated with l-asparaginase-containing chemotherapy \u2013 a single institution experience","volume":"94","author":"Zang","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ejca.2015.07.009_b0070","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0360-3016(02)02916-4","article-title":"Early stage nasal NK\/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality","volume":"54","author":"Cheung","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2015.07.009_b0075","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199202203260805","article-title":"Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer","volume":"326","author":"Schaake-Koning","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2015.07.009_b0080","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1200\/JCO.2009.23.8592","article-title":"Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK\/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study","volume":"27","author":"Kim","year":"2009","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejca.2015.07.009_b0085","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ijrobp.2004.06.210","article-title":"Phase II study of concomitant chemoradiotherapy in bulky refractory or chemoresistant relapsed lymphomas","volume":"61","author":"Girinsky","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2015.07.009_b0090","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1200\/JCO.1999.17.9.2915","article-title":"Definitive chemoradiotherapy for T4 and\/or M1 lymph node squamous cell carcinoma of the esophagus","volume":"17","author":"Ohtsu","year":"1999","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejca.2015.07.009_b0095","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa032641","article-title":"Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer","volume":"350","author":"Bernier","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2015.07.009_b0100","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3857\/roj.2011.29.3.174","article-title":"Treatment outcome of nasal natural killer\/T-cell lymphoma","volume":"29","author":"Lee","year":"2011","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.ejca.2015.07.009_b0105","article-title":"Long term results of a phase II trial with front-line concurrent chemoradiotherapy followed by consolidation chemotherapy for localized nasal natural killer\/T-cell lymphoma","author":"Tsai","year":"2014","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ejca.2015.07.009_b0110","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s00277-014-2137-6","article-title":"Concurrent chemoradiotherapy followed by l-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK\/T cell lymphoma: CISL08-01 phase II study","volume":"93","author":"Kim","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ejca.2015.07.009_b0115","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1200\/JCO.2012.45.6541","article-title":"Concurrent chemoradiotherapy for localized nasal natural killer\/T-cell lymphoma: an updated analysis of the Japan clinical oncology group study JCOG0211","volume":"30","author":"Yamaguchi","year":"2012","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejca.2015.07.009_b0120","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3892\/mco.2013.123","article-title":"Impact of dexamethasone, etoposide, ifosfamide and carboplatin as concurrent chemoradiotherapy agents for nasal natural killer\/T-cell lymphoma","volume":"1","author":"Hatayama","year":"2013","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.ejca.2015.07.009_b0125","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1200\/JCO.1994.12.6.1169","article-title":"ESHAP \u2013 an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study","volume":"12","author":"Velasquez","year":"1994","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejca.2015.07.009_b0130","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3324\/haematol.2009.006452","article-title":"Grupo Espa\u00f1ol de Linfomas\/Trasplante Aut\u00f3logo de M\u00e9dula Osea. R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: influence of prior autologous stem-cell transplantation on outcome","volume":"94","author":"Mart\u00edn","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.ejca.2015.07.009_b0135","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.leu.2402148","article-title":"Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx","volume":"15","author":"Ribrag","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.ejca.2015.07.009_b0140","unstructured":"Swerdlow SH, International Agency for Research on Cancer, World Health Organisation. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: International Agency for Research on Cancer; 2008."},{"key":"10.1016\/j.ejca.2015.07.009_b0145","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas. NCI Sponsored International Working Group","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejca.2015.07.009_b0150","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/cncr.27752","article-title":"First-line combination of gemcitabine, oxaliplatin, and l-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE\/IIE extranodal natural killer\/T-cell lymphoma","volume":"119","author":"Wang","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2015.07.009_b0155","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1002\/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1","article-title":"Frequent expression of P-glycoprotein\/MDR1 by nasal T-cell lymphoma cells","volume":"76","author":"Yamaguchi","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2015.07.009_b0160","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ajh.21256","article-title":"Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK\/T-cell lymphoma, nasal type","volume":"83","author":"Wang","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ejca.2015.07.009_b0165","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s12185-012-1189-4","article-title":"Current and future management of NK\/T-cell lymphoma based on clinical trials","volume":"96","author":"Yamaguchi","year":"2012","journal-title":"Int J Hematol"},{"key":"10.1016\/j.ejca.2015.07.009_b0170","doi-asserted-by":"crossref","DOI":"10.1007\/s00277-015-2395-y","article-title":"Radiotherapy and PGEMOX\/GELOX regimen improved prognosis in elderly patients with early-stage extranodal NK\/T-cell lymphoma","author":"Bi","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ejca.2015.07.009_b0175","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1023\/A:1011144911781","article-title":"CHOP followed by involved field radiation: is it optimal for localized nasal natural killer\/T-cell lymphoma?","volume":"12","author":"Kim","year":"2001","journal-title":"Ann Oncol Off J Eur Soc Med Oncol ESMO"},{"key":"10.1016\/j.ejca.2015.07.009_b0180","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1200\/JCO.1994.12.9.1814","article-title":"Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: results of a phase II Southwest Oncology Group study","volume":"12","author":"Hazuka","year":"1994","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejca.2015.07.009_b0185","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1200\/JCO.2001.19.10.2665","article-title":"Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis","volume":"19","author":"Imashuku","year":"2001","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejca.2015.07.009_b0190","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1748-717X-8-152","article-title":"Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for stage I-II natural killer\/T-cell lymphoma nasal type: dosimetric and clinical results","volume":"8","author":"Shen","year":"2013","journal-title":"Radiat Oncol Lond Engl"},{"key":"10.1016\/j.ejca.2015.07.009_b0195","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1038\/bcj.2014.88","article-title":"Concurrent IMRT and weekly cisplatin followed by GDP chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK\/T-Cell lymphoma","volume":"4","author":"Ke","year":"2014","journal-title":"Blood Cancer J"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804915006668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804915006668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T23:08:08Z","timestamp":1567033688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804915006668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":39,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0959804915006668"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2015.07.009","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)\/T-cell lymphoma, nasal type","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2015.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}